Literature DB >> 31492743

AhR Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Immunosuppressive Activity through Regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p That Target Anti-Inflammatory Genes.

Wurood Hantoosh Neamah1, Narendra P Singh1, Hasan Alghetaa1, Osama A Abdulla1, Saurabh Chatterjee2, Philip B Busbee1, Mitzi Nagarkatti1, Prakash Nagarkatti3.   

Abstract

The compound 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), an environmental contaminant, is a potent ligand for aryl hydrocarbon receptor (AhR). In the current study, we made an exciting observation that naive C57BL/6 mice that were exposed i.p. to TCDD showed massive mobilization of myeloid-derived suppressor cells (MDSCs) in the peritoneal cavity. These MDSCs were highly immunosuppressive and attenuated Con A-induced hepatitis upon adoptive transfer. TCDD administration in naive mice also led to induction of several chemokines and cytokines in the peritoneal cavity and serum (CCL2, CCL3, CCL4, CCL11, CXCL1, CXCL2, CXCL5, CXCL9, G-CSF, GM-CSF, VEGF, and M-CSF) and chemokine receptors on MDSCs (CCR1, CCR5, and CXCR2). Treatment with CXCR2 or AhR antagonist in mice led to marked reduction in TCDD-induced MDSCs. TCDD-induced MDSCs had high mitochondrial respiration and glycolytic rate and exhibited differential microRNA (miRNA) expression profile. Specifically, there was significant downregulation of miR-150-5p and miR-543-3p. These two miRNAs targeted and enhanced anti-inflammatory and MDSC-regulatory genes, including IL-10, PIM1, ARG2, STAT3, CCL11 and its receptors CCR3 and CCR5 as well as CXCR2. The role of miRs in MDSC activation was confirmed by transfection studies. Together, the current study demonstrates that activation of AhR in naive mice triggers robust mobilization of MDSCs through induction of chemokines and their receptors and MDSC activation through regulation of miRNA expression. AhR ligands include diverse compounds from environmental toxicants, such as TCDD, that are carcinogenic to dietary indoles that are anti-inflammatory. Our studies provide new insights on how such ligands may regulate health and disease through induction of MDSCs.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31492743      PMCID: PMC6755129          DOI: 10.4049/jimmunol.1900291

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

Review 1.  Recent advances in understanding the mechanisms of TCDD immunotoxicity.

Authors:  Nancy I Kerkvliet
Journal:  Int Immunopharmacol       Date:  2002-02       Impact factor: 4.932

2.  Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

Authors:  V Bronte; E Apolloni; A Cabrelle; R Ronca; P Serafini; P Zamboni; N P Restifo; P Zanovello
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

3.  Superantigen-primed T cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) replicate poorly following recall encounter.

Authors:  Laura Faulconer; Iris Camacho; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Arch Toxicol       Date:  2005-09-28       Impact factor: 5.153

4.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells.

Authors:  Iris A Camacho; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Arch Toxicol       Date:  2002-08-06       Impact factor: 5.153

5.  Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells.

Authors:  Iris A Camacho; Narendra Singh; Venkatesh L Hegde; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

6.  Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants.

Authors:  W D Loub; L W Wattenberg; D W Davis
Journal:  J Natl Cancer Inst       Date:  1975-04       Impact factor: 13.506

Review 7.  Functional role of AhR in the expression of toxic effects by TCDD.

Authors:  Junsei Mimura; Yoshiaki Fujii-Kuriyama
Journal:  Biochim Biophys Acta       Date:  2003-02-17

8.  T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.

Authors:  Nancy I Kerkvliet; David M Shepherd; Linda Baecher-Steppan
Journal:  Toxicol Appl Pharmacol       Date:  2002-12-01       Impact factor: 4.219

9.  Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors:  Iris A Camacho; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Toxicol Sci       Date:  2004-01-12       Impact factor: 4.849

10.  Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity.

Authors:  Michael T Fisher; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Toxicol Sci       Date:  2004-01-12       Impact factor: 4.849

View more
  25 in total

Review 1.  Cell-intrinsic view of the aryl hydrocarbon receptor in tumor immunity.

Authors:  Joseph W Dean; Liang Zhou
Journal:  Trends Immunol       Date:  2022-02-05       Impact factor: 16.687

2.  MiR-150-5p regulates the functions of type 2 innate lymphoid cells via the ICAM-1/p38 MAPK axis in allergic rhinitis.

Authors:  Lifeng Zhang; Wei Meng; Xiangjing Chen; Yunhong Ning; Meng Sun; Renzhong Wang
Journal:  Mol Cell Biochem       Date:  2022-01-06       Impact factor: 3.396

3.  Inherent hepatocytic heterogeneity determines expression and retention of edited F9 alleles post-AAV/CRISPR infusion.

Authors:  Qiang Wang; Lin Zhang; Guo-Wei Zhang; Jian-Hua Mao; Xiao-Dong Xi; Lu Jiang; Gang Lv; Jing Lu; Yan Shen; Zhu Chen; Jiang Zhu; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-19       Impact factor: 11.205

4.  AhR Activation Leads to Attenuation of Murine Autoimmune Hepatitis: Single-Cell RNA-Seq Analysis Reveals Unique Immune Cell Phenotypes and Gene Expression Changes in the Liver.

Authors:  Alkeiver S Cannon; Bryan Latrell Holloman; Kiesha Wilson; Kathryn Miranda; Nicholas Dopkins; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

5.  Interleukin-8 Receptor 2 (IL-8R2)-Deficient Mice Are More Resistant to Pulmonary Coccidioidomycosis than Control Mice.

Authors:  Aaron F Carlin; Suganya Viriyakosol; Sharon Okamoto; Lorraine Walls; Joshua Fierer
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

Review 6.  MDSC: Markers, development, states, and unaddressed complexity.

Authors:  Samarth Hegde; Andrew M Leader; Miriam Merad
Journal:  Immunity       Date:  2021-05-11       Impact factor: 31.745

7.  The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation.

Authors:  Jessica E Kenison; Zhongyan Wang; Kangkang Yang; Megan Snyder; Francisco J Quintana; David H Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

8.  Administration of Δ9-Tetrahydrocannabinol (THC) Post-Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity.

Authors:  Amira Mohammed; Hasan Alghetaa; Muthanna Sultan; Narendra P Singh; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Front Pharmacol       Date:  2020-06-16       Impact factor: 5.810

Review 9.  Myeloid Cell-Derived Arginase in Cancer Immune Response.

Authors:  Tomasz M Grzywa; Anna Sosnowska; Paweł Matryba; Zuzanna Rydzynska; Marcin Jasinski; Dominika Nowis; Jakub Golab
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

Review 10.  Recent advances in the development of AHR antagonists in immuno-oncology.

Authors:  Lijun Sun
Journal:  RSC Med Chem       Date:  2021-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.